Hanson McClain Advisors »

Recursion Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $348 35 9.97
2023-12-31 $345 35 9.89
2023-09-30 $383 50 7.66
2023-06-30 $261 35 7.49

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)

View all positions for Hanson McClain Advisors

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals